Summary

Market Size & Trends

The UK continuous glucose monitoring devices market size was valued at USD 532.2 million in 2024 and is expected to reach USD 1,952.8 million by 2033, growing at a CAGR of 15.5% from 2025 to 2033. The UK continuous glucose monitoring (CGM) devices market is growing due to rising diabetes prevalence, increasing demand for real-time glucose monitoring, and NHS support for CGM adoption, especially among insulin-treated Type 1 and Type 2 patients. Technological advancements, such as long-lasting sensors, smartphone integration, and non-invasive devices, further drive market penetration. Companies like Abbott, Dexcom, and newcomers like Yuwell are making CGMs more accessible and affordable. Government-backed initiatives focusing on prevention, remission, and personalized diabetes management also contribute to market expansion.

New research from the University of Leicester’s Diabetes Research Centre highlights the significant benefits of continuous glucose monitoring (CGM) for individuals with Type 2 diabetes in the UK, while also revealing barriers to its widespread adoption. CGM devices, usually worn on the arm, allow real-time tracking of blood glucose levels, enabling quicker, more accurate treatment decisions. The study, published in Diabetic Medicine, confirms that CGMs help reduce episodes of high and low blood sugar, support lifestyle improvements, and provide doctors with actionable data. However, it also identifies a lack of adequate training among healthcare professionals and resistance to new workflows as major hindrances.

More than 3.6 million people in the UK are living with diabetes, with about 90% diagnosed with Type 2. This chronic condition, though manageable through medication and lifestyle changes, remains a leading cause of preventable complications such as vision loss, kidney failure, and cardiovascular disease.

UK Continuous Glucose Monitoring Devices Market Report Scope Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the UK CGM devices market report based on product, connectivity, indication and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Standalone CGM Devices
o Devices
o Consumables (Receivers, Sensors, and Transmitters)
• Integrated CGM-Insulin Pump Systems
• Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
• Bluetooth
• 4G/Cellular
• NFC (Near Field Communication)
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Type 1 Diabetes
• Type 2 Diabetes
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmacies
• E-commerce
• Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. UK CGM Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. UK CGM Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. UK CGM Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. UK Continuous Glucose Monitoring Devices Market Product Movement Analysis
4.3. UK Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2024 to 2033 (USD Million)
4.4. Standalone CGM Devices
4.4.1. Standalone CGM Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.1. Devices
4.4.1.1.1. Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2. Consumables (Receivers, Sensors, and Transmitters)
4.4.1.2.1. Consumables (Receivers, Sensors, and Transmitters) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Integrated CGM-Insulin Pump Systems
4.5.1. Integrated CGM-Insulin Pump Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. UK CGM Devices Market: Connectivity Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. UK Continuous Glucose Monitoring Devices Market Connectivity Movement Analysis
5.3. UK Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Connectivity, 2024 to 2033 (USD Million)
5.4. Bluetooth
5.4.1. Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. 4G/Cellular
5.5.1. 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. NFC (Near Field Communication)
5.6.1. NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. UK CGM Devices Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. UK Continuous Glucose Monitoring Devices Market Indication Movement Analysis
6.3. UK Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Indication, 2024 to 2033 (USD Million)
6.4. Type 1 Diabetes
6.4.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Type 2 Diabetes
6.5.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. UK CGM Devices Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. UK Continuous Glucose Monitoring Devices Market End Use Movement Analysis
7.3. UK Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by End Use, 2025 to 2033 (USD Million)
7.4. Pharmacies
7.4.1. Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. E-commerce
7.5.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Dexcom
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Roche
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Medtronic
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Senseonics
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. GlucoRx
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. GlySens
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Nemaura Medical
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Ascensia
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Vively Health Pty Ltd
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives